Clinical trial

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

NCT04178980

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-01-01

PhasePHASE1

Study timeline

Study start (estimated)2020-01-01Date precision: day

Registry last updated2019-11-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Simvastatin Multiple Sclerosisunresolved

Interventions

Simvastatin in relapsing remitting multiple sclerosisDRUG

Sponsors & collaborators

Assiut Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04178980 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.